The Board of Directors has unanimously approved the funding of two research grants totaling $100,000 from the Hope Fund for 2024. Both projects have strong scientific merit and show promise into future Rett research. The Hope Fund was… Read More
Health Canada Accepts New Drug Submission for Trofinetide Acadia Pharmaceuticals is pleased to share that Health Canada has accepted their New Drug Submission (NDS) of trofinetide for the treatment of Rett Syndrome. Moreover, the treatment has been granted Priority Review to… Read More
2024 Research Grant Awarded
Leave a Comment
Last Updated: 04/26/2024 by Steve
The Board of Directors has unanimously approved the funding of two research grants totaling $100,000 from the Hope Fund for 2024. Both projects have strong scientific merit and show promise into future Rett research. The Hope Fund was… Read More
Health Canada Accepts a New Drug Submission
Leave a Comment
Last Updated: 04/24/2024 by Steve
Health Canada Accepts New Drug Submission for Trofinetide Acadia Pharmaceuticals is pleased to share that Health Canada has accepted their New Drug Submission (NDS) of trofinetide for the treatment of Rett Syndrome. Moreover, the treatment has been granted Priority Review to… Read More
19th Rett Classic Registration
Leave a Comment
Last Updated: 04/19/2024 by Steve
Registration for the 19th Rett Classic closes Friday,, May 24, 2024